Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Case Study · January 13, 2024

Euglycemic Ketoacidosis in Patients Without Diabetes After Introduction of SGLT2 Inhibitor for HFrEF

Diabetes Care


Additional Info

Diabetes Care
Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction
Diabetes Care 2024 Jan 01;47(1)140-143, MM Umapathysivam, J Gunton, SN Stranks, D Jesudason

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading